Belka C - Search Results

1

Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images.

Kurz C, Nijhuis R, Reiner M, Ganswindt U, Thieke C, Belka C, Parodi K, Landry G. Kurz C, et al. Among authors: belka c. Radiat Oncol. 2016 Apr 30;11:64. doi: 10.1186/s13014-016-0641-7. Radiat Oncol. 2016. PMID: 27129305 Free PMC article.

2

70 Gy or more: which dose for which prostate cancer?

Ganswindt U, Paulsen F, Anastasiadis AG, Stenzl A, Bamberg M, Belka C. Ganswindt U, et al. Among authors: belka c. J Cancer Res Clin Oncol. 2005 Jul;131(7):407-19. doi: 10.1007/s00432-005-0681-0. Epub 2005 May 11. J Cancer Res Clin Oncol. 2005. PMID: 15887028 Review.

3

Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.

Ganswindt U, Paulsen F, Corvin S, Eichhorn K, Glocker S, Hundt I, Birkner M, Alber M, Anastasiadis A, Stenzl A, Bares R, Budach W, Bamberg M, Belka C. Ganswindt U, et al. Among authors: belka c. BMC Cancer. 2005 Jul 28;5:91. doi: 10.1186/1471-2407-5-91. BMC Cancer. 2005. PMID: 16048656 Free PMC article.

4

Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I study.

Ganswindt U, Budach W, Jendrossek V, Becker G, Bamberg M, Belka C. Ganswindt U, et al. Among authors: belka c. Radiat Oncol. 2006 Apr 10;1:9. doi: 10.1186/1748-717X-1-9. Radiat Oncol. 2006. PMID: 16722607 Free PMC article. Clinical Trial.

5

[Recurrence of prostate cancer--value of salvage radiotherapy].

Belka C, Ganswindt U. Belka C, et al. Urologe A. 2006 Oct;45(10):1266-70. doi: 10.1007/s00120-006-1210-8. Urologe A. 2006. PMID: 17006699 Review. German.

6

Isobologram analysis of triple therapies.

Niyazi M, Belka C. Niyazi M, et al. Among authors: belka c. Radiat Oncol. 2006 Oct 17;1:39. doi: 10.1186/1748-717X-1-39. Radiat Oncol. 2006. PMID: 17044920 Free PMC article.

7

Counting colonies of clonogenic assays by using densitometric software.

Niyazi M, Niyazi I, Belka C. Niyazi M, et al. Among authors: belka c. Radiat Oncol. 2007 Jan 9;2:4. doi: 10.1186/1748-717X-2-4. Radiat Oncol. 2007. PMID: 17212832 Free PMC article.

8

Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique.

Ganswindt U, Paulsen F, Corvin S, Hundt I, Alber M, Frey B, Stenzl A, Bares R, Bamberg M, Belka C. Ganswindt U, et al. Among authors: belka c. Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):347-55. doi: 10.1016/j.ijrobp.2006.08.082. Int J Radiat Oncol Biol Phys. 2007. PMID: 17236960

9

Risk of second malignancies after prostate irradiation?

Müller AC, Ganswindt U, Bamberg M, Belka C. Müller AC, et al. Among authors: belka c. Strahlenther Onkol. 2007 Nov;183(11):605-9. doi: 10.1007/s00066-007-1786-y. Strahlenther Onkol. 2007. PMID: 17960335 Review.

10

Analysis of complex protein kinase B signalling pathways in human prostate cancer samples.

Jendrossek V, Henkel M, Hennenlotter J, Vogel U, Ganswindt U, Müller I, Handrick R, Anastasiadis AG, Kuczyk M, Stenzl A, Belka C. Jendrossek V, et al. Among authors: belka c. BJU Int. 2008 Aug;102(3):371-82. doi: 10.1111/j.1464-410X.2008.07703.x. Epub 2008 May 12. BJU Int. 2008. PMID: 18476967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

665 results

Search Page

Filters